je.st
news
Elan to payback 20pc to shareholders
2013-03-04 09:43:38| Biotech - Topix.net
Irish drugmaker Elan said it will give shareholders 20 percent of the royalty rights for multiple sclerosis drug Tysabri in a bid to stave off an approach for the company by U.S. investment firm Royalty Pharma .
Tags: shareholders
payback
elan
20pc
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||